Ballast Point Ventures and other investors have pumped $11.4 million into KeyView Labs Inc. KeyView, a consumer health products firm based in Sarasota, will use the funding to support the acquisition of Brain Research Labs and for growth capital, a statement from Ballast Point said. KeyView raised a total of $11.4 million from 10 investors in an equity and debt offering, according to a filing with the U.S. Securities and Exchange Commission. Ballast Point, a venture capital firm in St. Petersburg, said it invested $7 million. Drew Graham, a partner at Ballast Point, is listed as a director of KeyLabs on the SEC filing.
